US federal rescheduling now moves cannabinoid-based products to Schedule III. In our latest Trade To Black podcast, host Shadd Dales sits down with Aras Azatyan, CEO...
Tilray has announced a number of strategic initiatives to mark the next phase of its global growth, expanding across healthcare, cannabis and beverages, strengthening its...